RXST - RxSight, Inc.

7.69
-0.120   -1.560%

Share volume: 779,364
Last Updated: 03-06-2026
Medical Equipment/Ophthalmic Goods: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$7.81
-0.12
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
35%
Profitability 35%
Dept financing 23%
Liquidity 64%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.03%
1 Month
-6.90%
3 Months
-38.38%
6 Months
-21.37%
1 Year
-68.94%
2 Year
-84.74%
Key data
Stock price
$7.69
P/E Ratio 
0.00
DAY RANGE
$7.56 - $7.93
EPS 
-$0.80
52 WEEK RANGE
$6.32 - $27.13
52 WEEK CHANGE
-$68.94
MARKET CAP 
428.435 M
YIELD 
N/A
SHARES OUTSTANDING 
41.266 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.28
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$737,825
AVERAGE 30 VOLUME 
$800,480
Company detail
CEO: Ronald M. Kurtz
Region: US
Website: rxsight.com
Employees: 220
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Ophthalmic Goods
Sector: Manufacturing

RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.

Recent news